AI-Assisted Video Monitoring for Tracheostomy-Dependent Infants: A Proof-Of-Concept Study

Document Type

Article

Publication Date

6-5-2026

Publication Title

Laryngoscope

Abstract

Objective: To retrospectively evaluate Eyes-On, a patient-personalized AI-assisted video analysis system for frame-level detection of tracheostomy tube status and visual distress in tracheostomy-dependent infants. Methods: In an IRB-approved study, 25 tracheostomy-dependent infants aged ≤ 2 years underwent video recording during routine tracheostomy care and tube changes. Data were partitioned at the patient level (22 infants for model development; 3 withheld for staged evaluation). From edited clips, 10,000 frames were extracted and annotated by two blinded pediatric otolaryngologists. A YOLOv11 detector was trained to detect cannulation status, and a facial distress classifier was built using facial features and action unit signals. Generalized pretrained models were tested on held-out infants and then reevaluated after patient-specific calibration. Individualized thresholds were selected using decision curve analysis. Results: The pretrained cannulation detector achieved accuracy 0.736, sensitivity 0.806, specificity 0.667, mAP@50 0.645, and a 23.62% Not-Detected rate (n = 1200). After calibration, pooled evaluable-frame cannulation performance improved to accuracy 0.940, sensitivity 0.997, and specificity 0.874 (AUROC 0.962; AUPRC 0.918). The pretrained distress classifier achieved accuracy 0.825, sensitivity 0.877, specificity 0.770, and a 21.8% face-extraction failure rate. After calibration, evaluable-frame distress accuracy increased to 0.960 with sensitivity 0.974 and specificity 0.946 (AUROC 0.993; AUPRC 0.993). Conclusion: In this retrospective proof-of-concept study, patient-personalized video-based AI showed promising frame-level classification of tracheostomy-status and facial distress. These results reflect calibrated within-patient deployment and do not validate event-level outcomes, alarm thresholds, or standard monitoring modalities. Prospective real-world evaluation is needed before clinical adoption. Level of Evidence: 4.

Rights

© 2026 The American Laryngological, Rhinological and Otological Society, Inc.

Link to Full Text

Share

COinS